New ultrasensitive 32P-postlabelling method for the analysis of 3,N4-etheno-2′-deoxycytidine in human urine

Biomarkers

Volumn 11, Issue 4, 2006, Pages 329-340

  Sun, X ^a   Karlsson, A ^b   Bartsch, H ^a   Nair, J ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

3,N4 ethenodeoxycytidine; Human biomonitoring; Lipid peroxidation; Urinalysis

Indexed keywords

3,N4 ETHENODEOXYCYTIDINE; BIOLOGICAL MARKER; BROXURIDINE; CHROMIUM PHOSPHATE P 32; CREATININE; DEOXYRIBONUCLEOSIDE; UNCLASSIFIED DRUG; 3,N(4) ETHENODEOXYCYTIDINE; 3,N(4)-ETHENODEOXYCYTIDINE; DEOXYCYTIDINE; DEOXYRIBONUCLEOSIDE KINASES; DRUG DERIVATIVE; PHOSPHOTRANSFERASE;

ARTICLE; BIOLOGICAL MONITORING; CHEMICAL ANALYSIS; CONTROLLED STUDY; DNA ADDUCT; DROSOPHILA MELANOGASTER; ENZYME SUBSTRATE; HUMAN; LIPID PEROXIDATION; NON INVASIVE MEASUREMENT; NORMAL HUMAN; OXIDATIVE STRESS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SAMPLE; SENSITIVITY ANALYSIS; THIN LAYER CHROMATOGRAPHY; URINALYSIS; ANIMAL; CHEMICAL MODEL; CHEMISTRY; CLINICAL CHEMISTRY; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; TIME; ULTRAVIOLET RADIATION; URINE;

DROSOPHILA MELANOGASTER;

ANIMALS; BIOLOGICAL MARKERS; CHEMISTRY, ANALYTICAL; CHEMISTRY, CLINICAL; CHROMATOGRAPHY, THIN LAYER; DEOXYCYTIDINE; DNA ADDUCTS; DROSOPHILA MELANOGASTER; HUMANS; LIPID PEROXIDATION; MASS SPECTROMETRY; MODELS, CHEMICAL; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); TIME FACTORS; ULTRAVIOLET RAYS;

EID: 33747347038     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500600709606     Document Type: Article

References (24)

1. Bartsch, H and Nair, J. (2005) Accumulation of lipid peroxidation-derived DNA lesions: Potential lead markers for chemoprevention of inflammation-derived malignancies Mutation Research, 591, pp. 34-44.
2. Chen, HJ and Chang, CM. (2004) Quantification of urinary excretion of 1,N6-ethenoadenine, a potential biomarker of lipid peroxidation, in humans by stable isotope dilution, liquid chromatography-electrospray ionization-tandem mass spectrometry: Comparison with gas chromatography-mass spectrometry Chemical Research in Toxicology, 17, pp. 963-971.
3. Chen, HJ and Lin, TC and Hong, CL and Chiang, LC. (2001) Analysis of 3,N4-ethenocytosine in DNA and in human urine by isotope dilution gas chromatography/negative ion chemical ionization/mass spectrometry Chemical Research in Toxicology, 14, pp. 1612-1619.
4. Chen, HJ and Wu, CF and Hong, CL and Chang, CM. (2004) Urinary excretion of 3,N4-etheno-2'-deoxycytidine in humans as a biomarker of oxidative stress: Association with cigarette smoking Chemical Research in Toxicology, 17, pp. 896-903.
5. Chung, F-L and Chen, H-J and Nath, RG. (1996) Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts: a commentary Carcinogenesis, 17, pp. 2105-2111.
6. Cooke, MS and Evans, MD and Herbert, LJ and Lunec, J. (2000) Urinary 8-oxo-2'-deoxyguanosine-source, significance and supplements Free Radical Research, 32, pp. 381-397.
7. El Ghissassi, F and Barbin, A and Nair, J and Bartsch, H. (1995) Formation of 1,N6-ethenoadenosine and 3,N4-ethenocytosine by lipid peroxidation products and nucleic acid bases Chemical Research in Toxicology, 8, pp. 278-283.
8. Fernando, RC and Nair, J and Barbin, A and Miller, JA and Bartsch, H. (1996) Detection of 1,N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytidine by immunoaffinity/32P-postlabeling in liver and lung DNA of mice treated with ethyl carbamate (urethane) or its metabolites Carcinogenesis, 17, pp. 1711-1718.
9. Guengerich, FP. (1992) Roles of the vinyl chloride oxidation products 1-chloro-oxirane and 2-chloroacetaldehyde in the in vitro formation of etheno adducts of nucleic acid bases Chemical Research in Toxicology, 5, pp. 2-5.
10. Guichard, Y and Nair, J and Barbin, A and Bartsch, H.(1993) Immunoaffinity clean-up combined with 32P-postlabeling analysis of 1,N6-ethenoadenosine and 3,N4-ethenocytosine in DNA. In Postlabeling methods for the detection of DNA adducts. Science Publication Vol. 124. (pp. 263-269). Lyon: International Agency for Research on Cancer.
11. Hanaoka, T and Nair, J and Takahashi, Y and Sasaki, S and Bartsch, H and Tsugane, S. (2002) Urinary level of 1,N6-ethenodeoxyadenosine, a marker of oxidative stress, is associated with salt excretion and ω-6-polyunsaturated fatty acid intake in postmenopausal Japanese women International Journal of Cancer, 100, pp. 71-75.
12. Hillestrom, PR and Hoberg, AM and Weimann, A and Poulsen, HE. (2004) Quantification of 1,N6-ethenodeoxyadenosine in human urine by column-switching LC/APCI-MS/MS Free Radicals in Biology and Medicine, 36, pp. 1383-1392.
13. Hoberg, AM and Otteneder, M and Narnett, LJ and Poulsen, HE. (2004) Measurement of the malondialdehyde-2'-deoxyguanosine adduct in human urine by immuno-extraction and liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry Journal of Mass Spectrometry, 39, pp. 38-42.
14. Hussain, SP and Hofseth, LJ and Harris, CC. (2003) Radical causes of cancer National Reviews in Cancer, 3, pp. 276-285.
15. Johansson, M and Van Rompay, AR and Degreve, B and Balzarin, J and Karlsson, A. (1999) Cloning and characterization of the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster Journal of Biology and Chemistry, 274, pp. 23814-23819.
16. Leithauser, MT and Liem, A and Stewart, BC and Miller, EC and Miller, JA. (1990) 1,N6-ethenoadenosine formation, mutagenicity, and murine tumor induction as indicators of the generation of an electrophilic epoxide metabolite of the closely related carcinogens ethyl carbamate (urethane) and vinyl carbamate Carcinogenesis, 11, pp. 463-473.
17. NairJ. 1999. Lipid peroxidation-induced etheno-DNA adducts in humans. In: Exocylic DNA adducts in mutagenesis and Carcinogenesis.SingerB, BartschH, editors. IARC Scientific Publication Vol. 150. Lyon: International Agency for Research on Cancer. p. 55-61.
18. Nair, J and Barbin, A and Velic, I and Bartsch, H. (1999) Etheno-DNA-base adducts from endogenous reactive species Mutation Research, 424, pp. 59-69.
19. Nair, J and Carmichael, PL and Fernando, RC and Phillips, DH and Strain, AJ and Bartsch, H. (1998a) Lipid peroxidation-induced etheno-DNA adducts in the liver of patients with the genetic metal storage disorders Wilson's disease and primary hemochromatosis Cancer Epidemiology Biomarkers Prevention, 7, pp. 435-440.
20. Nair, J and Gal, A and Tamir, S and Tannenbaum, SR and Wogan, GN and Bartsch, H. (1998b) Etheno adducts in spleen DNA of SJL mice stimulated to overproduce nitric oxide Carcinogenesis, 19, pp. 2081-2084.
21. NairJ, GansaugeF, BegerH, DolaraP, WindeG, BartschH. 2006. Increased etheno-DNA adducts in affected tissues of patients suffering from Crohn's disease, Ulcerative colitis and Chronic Pancreatitis. Antioxidants and Redox Signaling 8:1003-10.
22. Nair, J and Vaca, CE and Velic, I and Mutanen, M and Valsta, LM and Bartsch, H. (1997) High dietary ω-6 polyunsaturated fatty acids drastically increase the formation of etheno-DNA base adducts in white blood cells of female subjects Cancer Epidemiology Biomarkers Prevention, 6, pp. 597-601.
23. Sun, X and Nair, J and Bartsch, H. (2004) A modified immuno-enriched 32P-postlabeling method for analyzing the malondialdehyde-deoxyguanosine adduct, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-pyrimido [1,2-α]purin-10(3H)one in human tissue samples Chemical Research in Toxicology, 17, pp. 268-272.
24. Swenberg, JA and Fedtke, N and Ciroussel, F and Barbin, A and Bartsch, H. (1992) Etheno adducts formed in DNA of vinyl chloride-exposed rats are highly persistent in liver Carcinogenesis, 13, pp. 727-729.